Drawing on the combined expertise of the Johns Hopkins Bloomberg School of Public Health and the Johns Hopkins School of Medicine, the Center for Drug Safety and Effectiveness serves as a nexus for ...

Gun Violence in the U.S. 2022: Examining the Burden Among Children and Teens ...

Americans are impacted by various forms of gun violence – including suicide, homicide, and unintentional deaths, as well as nonfatal gunshot injuries, threats, and exposure to gun violence in ...

Dr. René Najera is a distinguished public health professional currently serving as the Director of Public Health at a non-profit organization in Philadelphia. With a Master of Public Health and a ...

In 2021, there were at least 68 domestic violence-related homicides in South Carolina. 69% were by firearm. The county with the highest gun homicide rate in 2022 was Orangeburg County, with a rate ...

Firearm violence is a preventable public health tragedy affecting communities across the United States. In 2022, 48,204 1 people died by firearms in the United States — an average of one death every ...

The School is maintaining a searchable log of self-reported research and practice efforts Bloomberg School faculty are participating in and the current status of that work. Filters provide a means to ...

Bloomberg Professor of Disease Prevention, Department of Health, Behavior and Society Joanna Cohen (she/her) is the Bloomberg Professor of Disease Prevention, Chair of the Department of Health, ...

The term mental hygiene has a long history in the United States, having first been used by William Sweetzer in 1843. After the Civil War, which increased concern about the effects of unsanitary ...

Founded in 1998, the Institute for Global Tobacco Control works to build the evidence base informing efforts to effectively end the tobacco epidemic as soon as possible. We strive to produce and ...

Dr. Ballreich is a health economist specializing in three main areas: pharmaceutical economics and policy; economic evaluations alongside clinical studies; and high-cost/high-needs patient populations ...